From the College, Author at The Rheumatologist

Articles by From the College

Quality Payment Program 2021 Final Rule Released

From the College | December 15, 2020

ACR staff highlight essential 2021 MIPS reporting period information, as well as key changes from the 2020 to 2021 performance period.

The Leading Boldly Fundraising Campaign Makes Tremendous Progress

From the College | December 14, 2020

In 2018, the Rheumatology Research Foundation embarked on its third and most ambitious fundraising campaign, the Leading Boldly: Transforming Rheumatology campaign, with a goal of raising $75 million over five years. The campaign supports Foundation programs to recruit the best and brightest into the field, train rheumatology health professionals at all career stages and support…

Evaluation & Management Coding Changes in the 2021 Physician Fee Schedule Final Rule

From the College | December 8, 2020

Implementation of rate increases for evaluation and management services and other changes bring big updates to many Current Procedural Terminology codes.

After the 2020 Election, What’s in Store for Rheumatology Advocacy?

ACR Advocacy Staff | November 22, 2020

Despite high voter turnout and many new faces entering Congress, minimal power shifts in most levels of government will have implications for the ACR’s advocacy agenda in 2021.

ACR Advances Rheumatology Positions in American Medical Association Policies

From the College | November 22, 2020

At the American Medical Association House of Delegates Special Meeting held Nov. 13–17, 2020, the ACR’s delegation successfully led an effort to update AMA policies on home infusion and copay accumulators.

UnitedHealthcare Delays Copay Accumulator Policy

From the College | November 20, 2020

After ACR and other provider and patient organizations expressed concerns about a proposed copay accumulator policy set to take effect Jan. 1, 2021, UnitedHealthcare has indefinitely delayed its implementation but is continuing to explore options to reduce spending on specialty drugs.

Anthem Provides Clarification on Specialty Pharmacy Mandates

From the College | November 20, 2020

The ACR recently had an opportunity to speak with Anthem leadership to follow up on concerns about specialty pharmacy acquisition mandates being implemented by Anthem plans in California and New York. Anthem clarified that they do not expect these mandates to impact community-based providers. Beginning in December 2020, Anthem plans in certain states will require…

View On-Demand Sessions & Content from ACR Convergence 2020

From the College | November 12, 2020

Content from ACR Convergence 2020, including scientific sessions, posters, exhibits, and community hubs, is available to All-Access Pass and COVID-19 Pass participants to view and access on-demand through March 11, 2021. View sessions you missed and related Q&As with the speakers, read and catch up on posters, interact with exhibits and industry events, and view…

ACR Leads Resolution to Address Copay Accumulator Policies at AMA House of Delegates Meeting

From the College | November 6, 2020

If passed, the ACR-authored resolution will direct the AMA to advocate for copay accumulator bans at state and federal levels. Several other specialties and state medical associations have joined the resolution as cosponsors.

UHC Updates Rituximab Policy to Require Use of Biosimilars

From the College | October 19, 2020

As of Oct. 1, UnitedHealthcare (UHC) requires that patients fail to respond to both FDA-approved rituximab biosimilars prior to receiving approval for rituximab. Exception: Rituximab-pvvr (Ruxience) is not FDA approved for rheumatoid arthritis.